个人简历

1. 1999.09-2003.06 兰州大学生命科学学院生物学基地班，学士 （班主任：张迎梅教授）
2. 2003.09-2008.06 兰州大学生命科学学院生物化学与分子生物学研究所，硕博连读，理学博士（导师：王锐教授）
3. 2008.12-至今 浙江理工大学，生命科学学院讲师，副教授（2019.04 特聘教授）
4. 2013.10-2014.01 墨尔本Peter MacCallum Cancer Centre访问学者

研究领域

1. 小分子靶向药研发与肿瘤靶向治疗
2. 多肽药理学

近期论文

1. Lu Y, Zhang TF, Shi Y, Zhou HW, Chen Q, Wei BY, Wang X, Yang TX, Chinn YE, Kang J, Fu CY*. PFR peptide, one of the antimicrobial peptides identified from the derivatives of lactoferrin, induces necrosis in leukemia cells. Scientific Reports. 2016, 6: 20823. (corresponding author)
2. Zou Y, Guo CG, Yang ZG, Sun JH, Zhang MM*, Fu CY*. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model for hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery. Drug Design, Development and Terapy, 2016, 10: 1243-1255. (corresponding author)
3. Fang WJ*, Fu CY*, Chen XG, Mou XZ, Liu FL, Qian H, Zhao P, Zheng YL, Zheng Y, Deng J, Ye PJ, Wang YF, Zheng SS. Neurokinin-2 receptor polymorphism predicts lymph node metastasis in colorectal cancer patients. Oncology Letters, 2015, 9: 2003-2006. (co-first anthor)
4. Zhu XC, Zhang JL, Ge CT, Yu YY, Wang P, Yuan TF*, Fu CY*. Advances in cancer pain from bone metastasis. Drug Design, Development and Terapy, 2015, 9: 4239-4245. (corresponding author)
5. Zhu XC, Ge CT, Wang P, Zhang JL, Yu YY, Fu CY*. Analgesic effects of lappaconitine in leukemia bone pain in a mouse model. PeerJ, 2015, 3:e936. (corresponding author)
6. Fu CY*, Xia RL, Zhang TF, Lu Y, Zhang SF, Yu ZQ*, Jin T, Mou XZ*. Hemokinin-1(4-11)-induced analgesia selectively up-regulates δ-opioid receptor expression in mice. PLoS ONE, 2014, 9(2): e90446. (corresponding author)
7. Fu CY1, Chen W1, Jin YT*. The complete mitochondrial genome of Phrynocephalus guinanensis (Reptilia, Squamata, Agamidae). Mitochondrial DNA，2014， 1-2.
8. Xia RL, Lu Y, Zhu LN, Zhang SF, Zhao FK, Fu CY*. Different regulatory pathways are involved in the proliferative inhibition of two types of leukemia cell lines induced by paclitaxel. Oncology Reports, 2013, 30: 1853-1859. (corresponding author)
9. Zhu LN, Fu CY*, Zhang SF, Chen W, Jin YT, Zhao FK. Novel cytotoxic exhibition mode of antimicrobial peptide anoplin in MEL cells, the cell line of murine Friend leukemia virus- induced leukemic cells. Journal of Peptide Science, 2013, 19: 566-574. (corresponding author)
10. Xia RL, Fu CY*, Zhang SF, Jin YT, Zhao FK. Study on the distribution sites and the molecular mechanism of analgesia after intracerebroventricular injection of rat/mouse hemokinin-1 in mice. Peptides, 2013, 43: 113-120. (corresponding author)
11. Fu CY, Zhao YL, Dong L, Chen Q, Ni JM*, Wang R*. In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice. Brain, Behavior, and Immunity, 2008, 22: 850-860.
12. Fu CY, Kong ZQ, Long Y, Chen Q, Wang R*. Cardiovascular responses to rat/mouse hemokinin-1, a mammalian tachykinin peptide: Systemic study in anesthetized rats. European Journal of Pharmacology, 2007, 572 175–181.
13. Fu CY, Tang XL, Yang Q, Chen Q, Wang R*. Effects of rat/mouse hemokinin-1, a mammalian tachykinin peptide, on the antinociceptive activity of pethidine administered at the peripheral and supraspinal level. Behavioural Brain Research, 2007, 184: 39–46.
14. Fu CY, Yang Q, Wang KR, Kong ZQ, Chen Q, Wang R*. Rat/mouse hemokinin-1, a mammalian tachykinin peptide, markedly potentiates the antinociceptive effects of morphine administered at the peripheral and supraspinal level. Behavioural Brain Research, 2006, 170: 293–301.
15. Fu CY, Kong ZQ, Wang KR, Yang Q, Zhai K, Chen Q, Wang R*. Effects and mechanisms of supraspinal administration of rat/mouse hemokinin-1, a mammalian tachykinin peptide, on nociception in mice. Brain Research, 2005, 1056: 51–58.
16. Long Y1, Fu CY1, Tian XZ, Chen J, Han M, Wang R*. Mechanisms of relaxing response induced by rat/mouse hemokinin-1 in porcine coronary arteries: Roles of potassium ion and nitric oxide. European Journal of Pharmacology, 2007, 569: 119–125. (co-first anthor)
17. Kong ZQ1, Fu CY1, Chen Q, Wang R*. Cardiovascular responses to intravenous administration of human hemokinin-1 and its truncated form hemokinin-1(4-11) in anesthetized rats. European Journal of Pharmacology, 2008, 590: 310–316. (co-first anthor)
18. Chang HN, Liu BY, Qi YK (Qi, Yun-Kun), Zhou Y, Chen YP, Pan KM, Li WW, Zhou XM, Ma WW, Fu CY, Qi YM, Liu L, Gao YF. Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy. Angewandte Chemie-International Edition, 2015, 54: 11760-11764